Repository logo
 

The Nucleosome Remodeling and Deacetylase Complex NuRD Is Built from Preformed Catalytically Active Sub-modules

Published version
Peer-reviewed

Loading...
Thumbnail Image

Change log

Abstract

The nucleosome remodeling deacetylase (NuRD) complex is a highly conserved regulator of chromatin structure and transcription. Structural studies have shed light on this and other chromatin modifying machines, but much less is known about how they assemble and whether stable and functional sub-modules exist that retain enzymatic activity. Purification of the endogenous $\textit{Drosophila}$ NuRD complex shows that it consists of a stable core of subunits, while others, in particular the chromatin remodeler CHD4, associate transiently. To dissect the assembly and activity of NuRD, we systematically produced all possible combinations of different components using the MultiBac system, and determined their activity and biophysical properties. We carried out single-molecule imaging of CHD4 in live mouse embryonic stem cells, in the presence and absence of one of core components (MBD3), to show how the core deacetylase and chromatin-remodeling sub-modules associate $\textit{in vivo}$. Our experiments suggest a pathway for the assembly of NuRD $\textit{via}$ preformed and active sub-modules. These retain enzymatic activity and are present in both the nucleus and the cytosol, an outcome with important implications for understanding NuRD function.

Description

Journal Title

Journal of Molecular Biology

Conference Name

Journal ISSN

0022-2836
1089-8638

Volume Title

428

Publisher

Elsevier

Rights and licensing

Except where otherwised noted, this item's license is described as Attribution 4.0 International
Sponsorship
The Royal Society (uf120277)
Medical Research Council (MR/M010082/1)
Medical Research Council (MC_PC_12009)
European Commission (277899)
Wellcome Trust (098021/Z/11/Z)
This work was supported by the European Commission Framework Program 7 integrated project 4DCellFate (contract no. 277899), the Medical Research Council (MR/ M010082/1, to E.D.L.), and the Wellcome Trust (to I.B. and B.H.).